burger-menu close-panel
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Or Choose Category
Stem Cells & Therapies
On Women's Health
Chemical Abortion
Peer Reviewed
Fetal Development
Press Release
End of Life
Fetal Tissue, Stem Cells & Bioethics
Abortion
Maternal & Public Health
Research
Life & the Law
General
Trending Research
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

mifepristone

mifepristone

Or Choose Category
Stem Cells & Therapies
On Women's Health
Chemical Abortion
Peer Reviewed
Fetal Development
Press Release
End of Life
Fetal Tissue, Stem Cells & Bioethics
Abortion
Maternal & Public Health
Research
Life & the Law
General
Trending Research
9 results

Filter Results By

Filter Applied. Clear All

Latest Posts

December 7, 2023 Understanding Women’s Communication with Their Providers During Medication Abortion and Abortion Pill Reversal: An Exploratory Analysis Understanding Women’s Communication with Their Providers During Medication Abortion and Abortion Pill Reversal: An Exploratory Analysis December 7, 2023 Medication Abortion and Abortion Pill Reversal: An Exploratory Analysis on the Influence of Others in Women’s Decision-Making Medication Abortion and Abortion Pill Reversal: An Exploratory Analysis on the Influence of Others in Women’s Decision-Making November 20, 2023 Hoja Informativa: Riesgos y Complicaciones del Aborto Químico Hoja Informativa: Riesgos y Complicaciones del Aborto Químico
Research Type
By State
See All
By Author
See All
Reset All Filters

Did You Know ?

Did You Know ?

In the fourth week, the embryonic heart starts beating. The neural tube, which becomes the brain and spinal cord, forms. At this point, a woman has likely only been aware of her pregnancy for one week.

Did You Know ?

In the seventh week after conception, networks of neurons produce brain waves that have been recorded as early as 6 ½ weeks after conception. The embryo spontaneously moves his arms, hands, and legs, and may even hiccup. The embryo’s heart now has all four chambers.

Did You Know ?

By the seventeenth and eighteenth week after gestation, the fetus shows a clear response to pain in multiple studies, and at least one brain pathway is mature enough to create a perception of pain. The fetus also practices breathing, crying, and breastfeeding in the womb. The fetal heart has beat over 20 million times and circulates about 55 quarts of blood per day.

Did You Know ?

In the eighth month of pregnancy the fetal brain is ready to learn! At 32 weeks after conception, neurons are creating 40,000 new connections, called synapses, every second! With repeated exposures, the fetus can learn flavors, nursery rhymes, songs, and even words that she will recognize after birth!

9 results
mifepristone

Induced Abortion with Misoprostol Alone

As abortion limits have been implemented in many states in the wake of the Supreme Court’s Dobbs decision, some perplexing recommendations have been advanced by abortion advocates and their media allies.

Ingrid Skop, M.D., FACOG
May 18, 2023
ClosePlease loginn
mifepristone

Lozier Institute Statement on Abortion Pill Lawsuit Filed by Alliance Defending Freedom

Charlotte Lozier Institute, which in 2021 revealed a dramatic surge in abortion pill-related emergency room visits, today applauded Alliance Defending Freedom for challenging the U.S. Food and Drug Administration’s (FDA) erroneous and highly-politicized approval of the abortion drug regimen.

charlotte-lozier-institute Charlotte Lozier Institute
November 18, 2022
ClosePlease loginn
mifepristone

Dangerous Deception: Not Telling Your Doctor About Abortion Pill Use Increases Health Risks

A new analysis of 423,000 confirmed abortions debunks the common abortion industry narrative that “there’s no medical reason to tell a doctor about an abortion.”

charlotte-lozier-institute Charlotte Lozier Institute
May 25, 2022
ClosePlease loginn
mifepristone

Overlooked Dangers of Mifepristone, the FDA’s Reduced REMS, and Self-Managed Abortion Policies: Unwanted Abortions, Unnecessary Abortions, Unsafe Abortions

The failure of abortion providers to support and undertake prospective longitudinal studies of a nationally representative sample of women contributes to our belief that the ideological biases of abortion providers have led to a combination of disinterest, willful ignorance, or even a conspiracy to hide the widespread dangers of unwanted and contraindicated abortions.

David C. Reardon, Ph.D. Donna Harrison, M.D.
December 16, 2021
ClosePlease loginn
mifepristone

Public Health Threat: Connecticut DPH Data Shows More Women Using Risky Abortion Method

Half of all Connecticut abortions are performed with potentially dangerous drugs which multiple peer-reviewed studies have linked to higher rates of complications.

charlotte-lozier-institute Charlotte Lozier Institute
December 15, 2021
ClosePlease loginn
mifepristone

Public Health Threat: Chemical Abortion Leads to Significantly Higher Rate of ER Visits

As the Food and Drug Administration (FDA) works toward a December 16 decision on chemical abortion safeguards, a groundbreaking new study from Charlotte Lozier Institute (CLI) shows that increased access to abortion pills creates a significant public health risk.

charlotte-lozier-institute Charlotte Lozier Institute
November 16, 2021
ClosePlease loginn
featured-image
mifepristone

FDA’s Race to Defend Women From Dangerous Drugs

Abortion advocates—seeking to exploit the COVID-19 crisis to advance unfettered access to abortion-inducing drugs—found a friend in federal court.  In mid-July, Judge Theodore D. Chuang issued a preliminary injunction prohibiting the Food and Drug Administration (FDA) from enforcing certain health and safety practices that abortion providers are required to follow when prescribing the only FDA-approved abortion drug regimen.

Mary E. Harned, J.D.
August 19, 2020
ClosePlease loginn
featured-image
mifepristone

Issues in Law and Medicine Spring 2017 Summaries

Nora Sullivan, M.P.A
June 5, 2017
ClosePlease loginn

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image